Alternatives to Element Biosciences

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

A vertically-integrated procurement platform for the life sciences industry.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Automated wet lab for AI-driven protein design, enabling rapid synthesis, expression, and testing of thousands of protein designs.

Pioneering vision restoration therapies for severe retinal degenerations.

Developing a new generation of molecular diagnostics for at-home use, combining laboratory accuracy with rapid test simplicity.

Develops and distributes bioreactor technology for stem cell cultivation.

AI-enabled technology for cell biology research and biopharma development.

Advancing biopsy specimen stewardship and expanding access to precision oncology.

Developing breath-based diagnostics for lung diseases.

Developing an automated platform for liquid biopsy sample preparation.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

Global supplier of life science research tools, including antibodies, reagents, and assays.

Leveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.